Department of Urology, Skåne University Hospital, Malmö, Sweden.
Department of Urology, Coimbra University Hospital, Coimbra, Portugal.
Lancet Oncol. 2014 Nov;15(12):e549-61. doi: 10.1016/S1470-2045(14)70235-9. Epub 2014 Oct 26.
Local treatment of metastases such as metastasectomy or radiotherapy remains controversial in the treatment of metastatic renal cell carcinoma. To investigate the benefits and harms of various local treatments, we did a systematic review of all types of comparative studies on local treatment of metastases from renal cell carcinoma in any organ. Interventions included metastasectomy, radiotherapy modalities, and no local treatment. The results suggest that patients treated with complete metastasectomy have better survival and symptom control (including pain relief in bone metastases) than those treated with either incomplete or no metastasectomy. Nevertheless, the available evidence was marred by high risks of bias and confounding across all studies. Although the findings presented here should be interpreted with caution, they and the identified gaps in knowledge should provide guidance for clinicians and researchers, and directions for further research.
局部治疗转移灶,如转移瘤切除术或放疗,在转移性肾细胞癌的治疗中仍存在争议。为了研究各种局部治疗的获益和危害,我们对所有器官转移灶局部治疗的比较研究进行了系统综述。干预措施包括转移瘤切除术、放疗方式和无局部治疗。结果表明,与接受不完全或未行转移瘤切除术的患者相比,行完全性转移瘤切除术的患者具有更好的生存和症状控制(包括骨转移的疼痛缓解)。然而,所有研究均存在高偏倚和混杂风险,使得现有证据受到影响。尽管这里提出的结果应该谨慎解释,但它们和确定的知识空白应能为临床医生和研究人员提供指导,并为进一步研究指明方向。